Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport

  • Abhishek Gupta
  • , Vinay Kumar Singh
  • , Durgesh Kumar
  • , Pragya Yadav
  • , Santosh Kumar
  • , Muheeb Beg
  • , Kripa Shankar
  • , Salil Varshney
  • , Sujith Rajan
  • , Ankita Srivastava
  • , Rakhi Choudhary
  • , Vishal M. Balaramnavar
  • , Rabi Bhatta
  • , Narender Tadigoppula
  • , Anil Nilkanth Gaikwad

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science